# Safety of VSL#3 in Adult Asthmatics

> **NCT00852124** · PHASE1,PHASE2 · TERMINATED · sponsor: **University of Maryland, Baltimore** · enrollment: 3 (actual)

## Conditions studied

- Asthma

## Interventions

- **BIOLOGICAL:** VSL#3
- **BIOLOGICAL:** VSL#3 or placebo

## Key facts

- **NCT ID:** NCT00852124
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-02
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Inadequate recruitment
- **Last updated:** 2023-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00852124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00852124, "Safety of VSL#3 in Adult Asthmatics". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00852124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*